2 years ago
LONA
AnalystsGraig SuvannavejhGraig Suvannavejh's Stock Forecasts
AnalystsGraig Suvannavejh
Analyst Ranking
Top 8%
#379 out of 5286 analysts
Average Return
+14.67%
Win Rate
54%85 out of 158
Risk vs Reward
Poor
Good
Graig Suvannavejh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Terns Pharmaceuticals IncTERN | +550.49% | $8.14 | $52.95 | 2025-10-22 - 2026-05-04 | Buy |
Amylyx Pharmaceuticals IncAMLX | +357.23% | $3.46 | $15.82 | 2025-04-07 - 2026-04-06 | Buy |
Erasca IncERAS | +289.09% | $3.30 | $12.84 | 2025-12-09 - 2026-05-29 | Buy |
Insmed IncINSM | +266.11% | $20.36 | $74.54 | 2023-07-26 - 2024-07-26 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +235.17% | $4.35 | $14.58 | 2025-05-14 - 2026-05-13 | Buy |
Graig Suvannavejh Analyst Color
Get additional color on Graig Suvannavejh's coverage of popular stocks
2 years ago
IMCR
2 years ago
ITCI
2 years ago
IMCR
2 years ago
EYPT
2 years ago
AXSM
2 years ago
ADVM
3 years ago
BTAI
3 years ago
ITCI
3 years ago
AXSM
4 years ago
AXSM
4 years ago
HRMY
Graig Suvannavejh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Belite Bio IncBLTE | 3 | Buy | $215.00 | +49.12% | Maintains | 6 days ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Buy | $44.00 | +456.26% | Maintains | 10 days ago |
Verastem IncVSTM | 1 | Buy | $14.00 | +223.33% | Maintains | 18 days ago |
Ideaya Biosciences IncIDYA | 4 | Buy | $50.00 | +69.66% | Maintains | 25 days ago |
Axsome Therapeutics IncAXSM | 23 | Buy | $310.00 | +32.21% | Maintains | a month ago |
Amylyx Pharmaceuticals IncAMLX | 8 | Buy | $21.00 | +46.34% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 13 | Hold | $41.00 | -0.07% | Maintains | 2 months ago |
IMMIX Biopharma IncIMMX | 2 | Buy | $15.00 | +66.67% | Maintains | 2 months ago |
Insmed IncINSM | 11 | Buy | $206.00 | +92.69% | Maintains | 2 months ago |
Palvella Therapeutics IncPVLA | 2 | Buy | $250.00 | +111.04% | Maintains | 3 months ago |
Leonabio IncLONA | 4 | Buy | $10.00 | +4.82% | Upgrades | 3 months ago |
Erasca IncERAS | 1 | Buy | $5.00 | -61.06% | Maintains | 6 months ago |
Terns Pharmaceuticals IncTERN | 9 | Buy | $54.00 | +1.98% | Maintains | 6 months ago |
Harmony Biosciences Holdings IncHRMY | 21 | Buy | $46.00 | +45.62% | Maintains | 6 months ago |
Tarsus Pharmaceuticals IncTARS | 1 | Buy | $100.00 | +68.35% | Initiates Coverage On | 6 months ago |
Immatics NvIMTX | 4 | Buy | $23.00 | +99.83% | Maintains | 6 months ago |
Halozyme Therapeutics IncHALO | 5 | Hold | $56.00 | -15.84% | Maintains | 6 months ago |
Bioxcel Therapeutics IncBTAI | 9 | Hold | $4.00 | +241.88% | Maintains | 9 months ago |
Kala Bio IncKALA | 1 | Buy | $1,500.00 | +67,164.57% | Initiates Coverage On | 9 months ago |
Alector IncALEC | 5 | Buy | $3.50 | +62.04% | Upgrades | 10 months ago |
Neumora Therapeutics IncNMRA | 2 | Buy | $5.00 | +170.27% | Maintains | a year ago |
Adverum Biotechnologies IncADVM | 5 | Buy | $12.00 | +175.23% | Maintains | a year ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Hold | $0.50 | +825.93% | Downgrades | a year ago |
Immuneering CorpIMRX | 2 | Buy | $10.00 | +73.31% | Maintains | a year ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $11.00 | N/A | Maintains | a year ago |
Eyepoint IncEYPT | 5 | Buy | $26.00 | N/A | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 8 | Hold | $33.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 11 | Hold | $132.00 | N/A | Downgrades | a year ago |
Autolus Therapeutics PLCAUTL | 1 | Strong Buy | $7.60 | N/A | Upgrades | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 9 | Hold | $45.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $258.00 | N/A | Maintains | 3 years ago |
Rain Oncology IncRAIN2 | 5 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $35.00 | N/A | Maintains | 4 years ago |
Kodiak Sciences IncKOD | 4 | Hold | $8.00 | N/A | Maintains | 4 years ago |
Tg Therapeutics IncTGTX | 2 | Strong Sell | $26.00 | N/A | Downgrades | 5 years ago |
Disc Medicine IncIRON | 2 | Strong Buy | $18.00 | N/A | Maintains | 5 years ago |
Valneva SeVALN | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Design Therapeutics IncDSGN | 1 | Hold | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $31.00 | N/A | Initiates Coverage On | 5 years ago |
Vor Biopharma IncVOR | 1 | Strong Sell | $380.00 | N/A | Initiates Coverage On | 5 years ago |
Innate Pharma SaIPHA | 1 | Hold | $4.75 | N/A | Initiates Coverage On | 6 years ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $36.00 | N/A | Upgrades | 6 years ago |
Cytokinetics IncCYTK | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 6 years ago |
Lakefront Biotherapeutics NvLKFT | 1 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Prelude Therapeutics IncPRLD | 1 | Hold | $37.00 | N/A | Initiates Coverage On | 6 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Sell | $128.00 | N/A | Downgrades | 6 years ago |
Tricida IncTCDAQ | 1 | Hold | $10.00 | N/A | Downgrades | 6 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Hold | $15.00 | N/A | Initiates Coverage On | 6 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $29.00 | N/A | Initiates Coverage On | 6 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.